MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function
- PMID: 20378849
- PMCID: PMC2880481
- DOI: 10.1161/ATVBAHA.109.200873
MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function
Abstract
Objective: Regulation of vascular smooth muscle (VSM) proliferation and contractile differentiation is an important factor in vascular development and subsequent cardiovascular diseases. Recently, microRNAs (miRNAs) have been shown to regulate fundamental cellular processes in a number of cell types, but the integrated role of miRNAs in VSM in blood vessels is unknown. Here, we investigated the role of miRNAs in VSM by deleting the rate-limiting enzyme in miRNA synthesis, Dicer.
Methods and results: Deletion of Dicer in VSM results in late embryonic lethality at embryonic day 16 to 17, associated with extensive internal hemorrhage. The loss of VSM Dicer results in dilated, thin-walled blood vessels caused by a reduction in cellular proliferation. In addition, blood vessels from VSM-deleted Dicer mice exhibited impaired contractility because of a loss of contractile protein markers. We found this effect to be associated with a loss of actin stress fibers and partly rescued by overexpression of microRNA (miR)-145 or myocardin.
Conclusions: Dicer-dependent miRNAs are important for VSM development and function by regulating proliferation and contractile differentiation.
Conflict of interest statement
Disclosure: There are no conflicts of interest.
Figures






References
-
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. - PubMed
-
- Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV, Hannon GJ. Dicer is essential for mouse development. Nat Genet. 2003;35:215–217. - PubMed
-
- Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem. 2005;280:9330–9335. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL62572/HL/NHLBI NIH HHS/United States
- R01-HL081190/HL/NHLBI NIH HHS/United States
- R01 HL064793/HL/NHLBI NIH HHS/United States
- R01 HL096670/HL/NHLBI NIH HHS/United States
- P01 HL070295/HL/NHLBI NIH HHS/United States
- N01 HV028186/HL/NHLBI NIH HHS/United States
- R01-HL064793/HL/NHLBI NIH HHS/United States
- N01-HV-28186/HV/NHLBI NIH HHS/United States
- R01-HL061371/HL/NHLBI NIH HHS/United States
- R37 HL061371/HL/NHLBI NIH HHS/United States
- R01-HL096670/HL/NHLBI NIH HHS/United States
- R01 HL091168/HL/NHLBI NIH HHS/United States
- R01 HL062572/HL/NHLBI NIH HHS/United States
- P01-HL70295/HL/NHLBI NIH HHS/United States
- R01 HL081190/HL/NHLBI NIH HHS/United States
- HL091168/HL/NHLBI NIH HHS/United States
- R01 HL061371/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases